Careology, the connected health platform that transforms how people affected by a cancer diagnosis are supported and how they interact with their healthcare team launches on Monday 29th July.
Careology, has created intelligent technology that empowers people with cancer to feel in control of their own care and seamlessly connect them to their family and loved ones. The data-driven platform has been created to help make things a little less complicated at a time when life is complicated enough already.
Paul Landau, CEO and Founder of Careology, was one of the first people to identify the potential health applications of wearable technology back in 2005 with his company Fitbug. However, it was the personal experience of witnessing his wife’s cancer diagnosis and subsequent treatment journey in 2016 that inspired this venture.
In 2018, Careology raised £400k to build the platform, which is now available for iOS-operated devices. Early advisors and investors include Carl Uminski, named by The Drum as the most influential person in mobile, Nick Hynes, who has established some of the most successful fast-growth digital companies of the last two decades, Fergus Kee, ex Managing Director Bupa UK and North America and Dr. Henry Carleton, serial health tech entrepreneur.
Carl Uminski comments: “Knowing Paul’s experience in delivering pioneering health-tech solutions and his first hand understanding of the needs of the market, I was interested in investing in Careology from the outset. The platform has huge potential to transform cancer care and I have been thoroughly impressed by the team’s rapid approach to building a powerful technology solution that is already resonating strongly in the market.”
The facts about cancer are sobering. Half of us will be diagnosed with cancer during our lifetime. Worldwide, 18 million new cases will be diagnosed every year, costing a staggering $895 billion, and 2.5 million of these new cases will be in the UK and US. Worldwide cancer incidence is also expected to rise to 29.5 million by 2040.
Paul comments: “We’ve been working tirelessly to create an advanced technology solution that deals with cancer care differently, employing consumer-oriented design, blended with clinically robust thinking and data science. Careology not only provides useful tools, but also looks and feels like any great app you would want to use as part of everyday life – we want to create something that is for people, not patients. Ultimately, we see Careology filling a void that currently exists for people living with cancer, their families and the healthcare professionals that manage their care.”
People with cancer are relied upon to make daily judgement calls about when to contact their healthcare provider about their health, and misjudgements can lead to serious complications. An estimated 50-75% of patients undergoing their first chemotherapy cycle report serious complications.
To address this challenge, Careology ProfessionalTM, the platform that supports the interaction with healthcare professionals, will allow clinicians involved in cancer care to monitor their patients’ overall health in between appointments. This provides healthcare teams the chance to intervene early, transforming the efficiency and delivery of care. The full service will be available before the end of 2019”.
The overarching vision for Careology is to become the global leader in patient-centred care – helping patients feel in control, supported and connected, to help achieve the best possible outcome. Initially focusing on the UK and US healthcare sectors, it will be followed by further expansion into selected markets with a clear emphasis on supporting healthcare providers and payers.
Careology is currently securing the funding required to ensure they are in a position to maximise the clear potential of this business proposition. This will include securing strategic partnerships that will enable the business to scale-up effectively and quickly. The Careology app is available from Monday 29th July on the App store and will be available to Android users this Autumn.